Consolidated Statements of Convertible Preferred Stock and Shareholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Conversion of preferred stock to common stock	Conversion of stock warrants to common stock	Conversion of SAFE instruments to common stock	Initially reported	Retroactive application of Exchange Ratio	Special stock	Special stock Initially reported	Special stock Retroactive application of Exchange Ratio	Common stock	Common stock Conversion of preferred stock to common stock	Common stock Conversion of stock warrants to common stock	Common stock Conversion of SAFE instruments to common stock	Common stock Initially reported	Common stock Retroactive application of Exchange Ratio	Additional paid in capital	Additional paid in capital Conversion of preferred stock to common stock	Additional paid in capital Conversion of stock warrants to common stock	Additional paid in capital Conversion of SAFE instruments to common stock	Additional paid in capital Initially reported	Additional paid in capital Retroactive application of Exchange Ratio	Accumulated other comprehensive loss	Accumulated other comprehensive loss Initially reported	Accumulated other comprehensive loss Retroactive application of Exchange Ratio	Accumulated deficit	Accumulated deficit Initially reported	Accumulated deficit Retroactive application of Exchange Ratio
Temporary equity, beginning balance (in shares) at Dec. 31, 2019	101,849,342				50,588,630	51,260,712
Temporary equity, beginning balance at Dec. 31, 2019	$ 35,691				$ 35,691	$ 0
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of preferred shares, net of issuance costs (in shares)	16,037,640
Issuance of preferred shares, net of issuance costs	$ 10,241
Temporary equity, ending balance (in shares) at Dec. 31, 2020	117,886,982
Temporary equity, ending balance at Dec. 31, 2020	$ 45,932
Beginning balance (in shares) at Dec. 31, 2019							2	1	1	7,785,647				3,867,136	3,918,511
Beginning balance at Dec. 31, 2019	(20,735)				(20,735)		$ 0	$ 0	$ 0	$ 1				$ 4	$ (3)	$ 999				$ 996	$ 3	$ 0	$ 0	$ 0	$ (21,735)	$ (21,735)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,437)																								(7,437)
Share-based compensation	$ 278															278
Shares issued for stock options exercised (in shares)	113,247									375,179
Shares issued for stock options exercised	$ 32															32
Stock conversion (in shares)							(2)			2
Ending balance (in shares) at Dec. 31, 2020							0			8,160,828
Ending balance at Dec. 31, 2020	(27,862)						$ 0			$ 1						1,309						0			(29,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(4,056)				(4,172)
Ending balance at Mar. 31, 2021	$ (31,475)				(31,591)
Temporary equity, beginning balance (in shares) at Dec. 31, 2020	117,886,982
Temporary equity, beginning balance at Dec. 31, 2020	$ 45,932
Beginning balance (in shares) at Dec. 31, 2020							0			8,160,828
Beginning balance at Dec. 31, 2020	(27,862)						$ 0			$ 1						1,309						0			(29,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(60,389)				(60,935)
Ending balance at Jun. 30, 2021	$ (87,440)				(87,986)
Temporary equity, beginning balance (in shares) at Dec. 31, 2020	117,886,982
Temporary equity, beginning balance at Dec. 31, 2020	$ 45,932
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of preferred stock to common stock (in shares)	(117,886,982)
Conversion of preferred stock to common stock	$ (45,932)
Temporary equity, ending balance (in shares) at Dec. 31, 2021	0
Temporary equity, ending balance at Dec. 31, 2021	$ 0
Beginning balance (in shares) at Dec. 31, 2020							0			8,160,828
Beginning balance at Dec. 31, 2020	(27,862)						$ 0			$ 1						1,309						0			(29,172)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(142,191)																								(142,191)
Other comprehensive loss	(4)																					(4)
Share-based compensation	$ 11,380															11,380
Shares issued for stock options exercised (in shares)	5,741,547									4,756,937
Shares issued for stock options exercised	$ 462															462
Shares issued for stock warrants exercised (in shares)										199,315
Shares issued for stock warrants exercised	30															30
Stock conversion (in shares)											121,038,967	582,509	20,080,464
Stock conversion		$ 45,932	$ 3,011	$ 170,318							$ 12		$ 2				$ 45,920	$ 3,011	$ 170,316
Reverse recapitalization and PIPE financing, net (in shares)										28,548,017
Reverse recapitalization and PIPE financing, net	148,199									$ 3						148,196
Ending balance (in shares) at Dec. 31, 2021							0			183,367,037
Ending balance at Dec. 31, 2021	209,275						$ 0			$ 18						$ 380,624						$ (4)			$ (171,363)
Beginning balance at Mar. 31, 2021	(31,475)				(31,591)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(56,333)				(56,571)
Ending balance at Jun. 30, 2021	$ (87,440)				$ (87,986)